Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |